SC-003 in combination with ABBV-181: Clinical Trials

1 trial of SC-003 in combination with ABBV-181, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow SC-003 in combination with ABBV-181: new trials by email Literature Review of SC-003 in combination with ABBV-181 trials Research Report on SC-003 in combination with ABBV-181

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer
SC-003, SC-003 in combination with ABBV-181 - Ovarian Cancer
Phase 1TerminatedStemcentrx742015-08-012019-01-04

Conditions studied

Ovarian Neoplasms (1)

Sponsors

Stemcentrx (1)

Countries

United States (1)

Top investigators

Julia Lawrence, D.O. (1)

Results publications

PMID 32513564